Bionano Genomics (BNGO) Change in Receivables (2017 - 2026)

Bionano Genomics has disclosed Change in Receivables across 10 years of filings, most recently posting -$1.1 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at -$1.1 million, up 23.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $779000.0 (up 117.19% YoY), and the FY2025 annual result was $448000.0, up 110.82% from the prior year.
• Change in Receivables came in at -$1.1 million for Q1 2026 at Bionano Genomics, down from $674000.0 in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $1.2 million in Q3 2022 to a low of -$2.1 million in Q2 2024.
• The 5-year median for Change in Receivables is $141000.0 (2025), against an average of -$12411.8.
• Across the five-year window, Change in Receivables jumped 611.46% in 2022 and slumped 347.6% in 2024, its largest moves.
• Bionano Genomics' Change in Receivables stood at $1.1 million in 2022, then sank by 41.81% to $650000.0 in 2023, then tumbled by 120.46% to -$133000.0 in 2024, then jumped by 606.77% to $674000.0 in 2025, then sank by 258.31% to -$1.1 million in 2026.
• The last three Change in Receivables figures came in at -$1.1 million (Q1 2026), $674000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.